Emory Patients Part Of Drug Trial For Potential COVID-19 Treatment

, |

April 22nd, 2020

Emory has more than 80 patients involved in its part of the trial. The patients were hospitalized and diagnosed with pneumonia caused by COVID-19, said Dr. Aneesh Mehta, who is Emory’s principal investigator. The Atlanta patients are at four hospitals – Emory University Hospital, Emory University Hospital Midtown, Emory Saint Joseph’s Hospital and Grady Memorial Hospital.

wikimedia commons

Some Emory patients with COVID-19 are part of a clinical trial of an antiviral drug that has reportedly proved effective among patients in Chicago who have severe illness.

The Emory trial of remdesivir is part of a National Institutes of Health study that’s separate from the Chicago drug trial.

There’s no FDA-approved treatment for COVID-19 , but remdesivir is getting a lot of positive buzz in scientific circles.

Related

Top Stories